Management

CHIEF EXECUTIVE OFFICER
Hugh O’Dowd, M.B.A.
Neon Therapeutics’ chief executive officer, Hugh O’Dowd, joined the company in 2016, bringing more than 20 years of expertise in pharmaceutical leadership and moving important oncology therapies from clinical development through commercialization. Hugh joined Neon Therapeutics from Novartis
CHIEF FINANCIAL OFFICER
Yasir Al-Wakeel, B.M., B.Ch.
Yasir B. Al-Wakeel, B.M. B.Ch., joined Neon Therapeutics in 2017 as our first full-time chief financial officer. Most recently, Yasir served as chief financial officer and head of corporate development of Merrimack Pharmaceuticals, where he spearheaded the strategic sale of Onivyde ®  and generic
CHIEF BUSINESS OFFICER
Robert Ang, M.D., M.B.A.
Robert Ang is chief business officer at Neon, where he has responsibilities spanning fundraising, partnering, intellectual property and public relations. Prior to Neon, Robert served as senior vice president of business development at Bavarian Nordic, an international biotechnology company
PRESIDENT OF RESEARCH & DEVELOPMENT
Richard Gaynor, M.D.
Richard Gaynor joined Neon Therapeutics in 2016, most recently holding the position of senior vice president of global product development and medical affairs since 2013 at Lilly Oncology. In total, Richard spent 15 years in related senior roles at Lilly Oncology where he led preclinical and early
VICE PRESIDENT OF PRODUCT DEVELOPMENT
Kelledy Manson
Kelledy Manson is Neon’s vice president of product development. She has nearly 25 years experience in the biopharmaceutical industry, having been involved in all aspects of development in addition to program and alliance management. Kelledy has held in leadership roles at a number of companies.
VICE PRESIDENT OF HUMAN RESOURCES
Teresa Regan
Teresa (Terry) Regan joined Neon Therapeutics in 2017 as vice president of human resources. Terry has over 20 years of human resources experience in the biotechnology space. As the first head of human resources at Cubist Pharmaceuticals, she was instrumental in supporting the company through its